Published in Ann N Y Acad Sci on September 16, 1998
Intracellular devastation in heart failure. Heart Fail Rev (2008) 1.04
The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseases. Biochem Biophys Res Commun (2007) 0.98
Effects of phosphocreatine on SR Ca(2+) regulation in isolated saponin-permeabilized rat cardiac myocytes. J Physiol (2002) 0.86
Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus. Mol Pharmacol (2012) 0.85
Trichloroethylene disrupts cardiac gene expression and calcium homeostasis in rat myocytes. Toxicol Sci (2008) 0.84
Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes. Am J Physiol Cell Physiol (2009) 0.82
Reduced SERCA2a converts sub-lethal myocardial injury to infarction and affects postischemic functional recovery. J Mol Cell Cardiol (2008) 0.79
Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart. Heart Fail Rev (2014) 0.75
The cardiac calsequestrin gene transcription is modulated at the promoter by NFAT and MEF-2 transcription factors. PLoS One (2017) 0.75
Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats. PLoS One (2017) 0.75
A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med (1995) 4.99
Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation (1997) 3.58
Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med (1993) 3.53
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet (2002) 3.18
Altered myocardial force-frequency relation in human heart failure. Circulation (1992) 3.12
Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res (1994) 2.82
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet (1992) 2.66
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation (1991) 2.61
Alterations of skeletal muscle in chronic heart failure. Circulation (1992) 2.58
Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation (1999) 2.45
PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem (1994) 2.44
Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation (1995) 2.27
Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J (2000) 2.15
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J (2006) 2.07
Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation (1998) 2.06
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Circ Res (1994) 2.04
Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res (1989) 1.98
Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ Res (1999) 1.87
Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation (1995) 1.86
Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol (1989) 1.75
Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest (1993) 1.73
Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart (1997) 1.72
Endothelial function in chronic congestive heart failure. Am J Cardiol (1992) 1.69
Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation (1996) 1.67
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res (1999) 1.67
Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation (1991) 1.61
The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts. Cardiovasc Res (2003) 1.59
Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res (2000) 1.57
Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. J Clin Invest (1996) 1.56
Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J (1994) 1.54
Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation (1992) 1.50
Calcium handling proteins in the failing human heart. Basic Res Cardiol (1997) 1.48
Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med (2001) 1.45
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol (2000) 1.43
Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium. Eur Heart J (2002) 1.43
Reduced plasma L-arginine in hypercholesterolaemia. Lancet (1992) 1.42
Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension--assessed by cold pressor testing. Eur Heart J (1999) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Continuous arteriovenous haemoperfusion (CAVHP) for treatment of paraquat poisoning. Nephrol Dial Transplant (1992) 1.41
Scoring system for nosocomial pneumonia in ICUs. Intensive Care Med (1996) 1.41
[Diagnostic value of various echo- and Doppler echocardiography methods in quantifying mitral valve stenosis]. Z Kardiol (1996) 1.39
Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension. Circulation (1992) 1.39
Long-term clinical experience with the EGM width detection criterion for differentiation of supraventricular and ventricular tachycardia in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol (2000) 1.38
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation (1997) 1.34
Differences in Ca(2+)-handling and sarcoplasmic reticulum Ca(2+)-content in isolated rat and rabbit myocardium. J Mol Cell Cardiol (2000) 1.30
Slow breathing reduces sympathoexcitation in COPD. Eur Respir J (2008) 1.28
Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia (2010) 1.23
Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics (2008) 1.22
Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res (2001) 1.21
Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation (1998) 1.20
Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints. Nucl Med Commun (2002) 1.19
Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation (1994) 1.17
Flow-dependent coronary artery dilatation in humans. Circulation (1989) 1.16
Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation (2000) 1.14
An epidemiological study assessing the relative importance of airborne and direct contact transmission of microorganisms in a medical intensive care unit. J Hosp Infect (1990) 1.14
Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol (1993) 1.14
Characterization of activators and inhibitors of protein kinase C mu. Eur J Biochem (1995) 1.13
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation (1996) 1.12
Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation (1996) 1.12
Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations. J Mol Cell Cardiol (1998) 1.11
Preservation of contractile characteristics of human myocardium in multi-day cell culture. J Mol Cell Cardiol (1999) 1.09
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation (1989) 1.09
Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients. Aliment Pharmacol Ther (2015) 1.09
Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism. Am J Cardiol (1980) 1.09
Beta-blocker withdrawal syndrome? Lancet (1979) 1.08
Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet (1992) 1.07
ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J (1990) 1.05
Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation (1999) 1.05
Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol (1996) 1.05
Role of endogenous bradykinin in human coronary vasomotor control. Circulation (1995) 1.04
[Prolongation of hospital stay by nosocomial pneumonia and wound infection]. Dtsch Med Wochenschr (1991) 1.03
Impaired contractile performance of cultured rabbit ventricular myocytes after adenoviral gene transfer of Na(+)-Ca(2+) exchanger. Circ Res (2000) 1.03
QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards. Cardiovasc Drugs Ther (1991) 1.03